the authors of this work will conduct a randomized controlled trial intended to examine different amplitude-modulated frequencies of interferential current on different measures related to chronic trigger points located in the upper trapezius muscle.
Age range
17 Years – 50 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Active Range of motion (AROM) for cervical spine.
Timeframe: at baseline
Active Range of motion (AROM) for cervical spine.
Timeframe: at 4 weeks
Active Range of motion (AROM) for cervical spine.
Timeframe: at 4 weeks after the end of the treatment (follow-up)
Pain pressure threshold by pressure algometer
Timeframe: at baseline
Pain pressure threshold by pressure algometer
Timeframe: at 4 weeks
Pain pressure threshold by pressure algometer
Timeframe: at 4 weeks after the end of the treatment (follow-up)
Function using neck disability index
Timeframe: at baseline
Function using neck disability index
Timeframe: at 4 weeks
Function using neck disability index
Timeframe: at 4 weeks after the end of treatment (follow-up)
number of painful episode in the trapezius muscle
Timeframe: at baseline
number of painful episode in the trapezius muscle
Timeframe: at 4 weeks
number of painful episode in the trapezius muscle
Timeframe: at 4 weeks after the end of treatment (follow-up)